GOLDENWELL BIOTECH, INC. Form SCHEDULE 13D — Oct 9, 2026
Ming Zhou filed a Schedule 13D disclosing beneficial ownership of 20,000,000 shares of Goldenwell Biotech common stock, approximately 20.2% of the 99,000,000 shares outstanding as of August 11, 2026. The shares were gifted to Ms. Zhou on October 8, 2026 by Shuang Liu, the company's CEO, and Ms. Zhou was appointed a director of the issuer the same day.
Key figures
- Shares Outstanding
- 99000000
- Gift date
- 2026-10-08
- Shares owned
- 20000000
- Percent of class
- 20.2%
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.